Skip to main content

Cue Biopharma, Inc.

CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001645460

In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.

Members of Congress who traded CUE

No member of Congress has reported a trade in Cue Biopharma, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.